Skip header and navigation

11 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Table Infectious Disease
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR Table EOC
November 2, 2020 What is the risk of reinfection from COVID-19? [Update] EOC032401v3 RR EOC
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 19, 2020 Risk estimates for clinical factors predicting severity and/ or mortality associated with COVID-19 EPM050901 RR Table Epidemiology & Modelling
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory
April 15, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402 RR Laboratory
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory

11 records – page 1 of 1.